骨骼肌线粒体蛋白酶LONP1在缺少运动导致的肌肉衰减中的调控功能与作用机制
批准号:
32100922
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
付婷婷
依托单位:
学科分类:
整合生理学与整合生物学
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
付婷婷
中文摘要
肌肉健康是健康体魄的根本保证,肌肉衰减在老年人中发病率高达30%,肌肉衰减导致老年人行动不便,还会引发肥胖、糖尿病等代谢综合征,严重影响老年人健康水平和生活质量。线粒体质量对于骨骼肌功能维持及其应答生理病理反应所必需,肌肉线粒体质量如何控制及在肌萎缩中的功能却十分不清楚。我们曾发现骨骼肌线粒体自噬对于骨骼肌代谢功能维持和运动能力至关重要。本课题的前期研究表明线粒体蛋白稳态关键调控因子LONP1能够响应肌肉废用信号,在缺乏运动诱导的肌肉衰减早期显著下调。此外,骨骼肌特异性LONP1敲除小鼠导致线粒体蛋白稳态失衡,严重影响肌肉含量及运动能力。因此,我们提出:线粒体蛋白酶LONP1能响应肌肉废用信号,在肌肉衰减发生发展中发挥重要功能。为证实这一假设我们将分别从整体,细胞和线粒体亚细胞水平阐明LONP1介导的线粒体蛋白质稳态控制在肌肉衰减发生发展中的作用与机制,为肌肉衰减的防治新途径提供实验依据。
英文摘要
Healthy muscles constitute the fundamental basis of a healthy body. The incidence rate of sarcopenia caused by aging is as high as 30% among the olds, sarcopenia causes physical inactivity to the elderly, and also causes metabolic syndrome such as obesity and diabetes, which seriously affects their quality of health and life. Mitochondrial quality control is crucial for skeletal muscle function and its response to physiological or pathological stimulations. However, how to control the quality of muscle mitochondria and its function in muscular atrophy remains unclear. We have previously demonstrated that skeletal muscle mitophagy play a crucial role in muscle metabolism and exercise capacity. In this study, we have found that the mitochondrial protein homeostasis key regulator LONP1 significantly decreased in the early stage of muscular atrophy caused by muscle disuse in mice. Moreover, loss of mice muscle LONP1 resulted in mitochondrial protein accumulation, mitochondrial protein homeostasis disturbed, muscle mass and exercise capacity significantly decreased. Therefore, we propose that physical inactivity associated mitochondrial protease LONP1 loss is crucial for regulating the development of sarcopenia. To verify this hypothesis, we will analyze a series of animal model with physiological, molecular and cellular methods to elucidate the role of LONP1 mediated mitochondrial quality control in the occurrence and development of sarcopenia, which will providing experimental instructions for new therapeutic strategies of sarcopenia.
作为重要的代谢器官,骨骼肌和脂肪组织的功能衰退会导致多种人类疾病的发生。线粒体是骨骼肌和脂肪代谢功能及其应答生理或病理反应的关键,但人们对于线粒体质量是如何控制及其代谢调节功能却十分不清楚。在本项目经费支持下,我们充分利用小鼠遗传学模型,探究线粒体蛋白质稳态控制在骨骼肌/脂肪及组织间代谢交流中的功能与机制。我们有如下的发现:1)LONP1依赖的线粒体蛋白质稳态控制对肌肉含量和功能维持至关重要;2)依赖蛋白酶LONP1的线粒体蛋白水解重排调控白色脂肪细胞的命运转变;3)骨骼肌线粒体蛋白稳态应激反应UPRmt可以长距离调节肝脏和脂肪代谢,决定整体代谢健康;4)骨骼肌线粒体蛋白稳态失衡会介导骨质流失,肌源性分泌因子FGF21对骨代谢有重要调控作用。这些发现揭示了线粒体蛋白酶LONP1在控制骨骼肌和脂肪组织稳态至关重要,且骨骼肌线粒体蛋白稳态介导骨骼肌与其他组织之间的交流,决定代谢健康。这些发现也突出了靶向线粒体蛋白质质量控制途径以对抗肥胖、肌少症、骨质疏松等代谢疾病的潜在治疗机会。
组蛋白甲基转移酶MLL4对骨骼肌纤维类型和代谢功能的调控作用与机制研究
-
批准号:32071136
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:付婷婷
-
依托单位:
国内基金
海外基金